LOXAPAC, oral solution bottle, 30 ml
Active ingredients: Loxapine
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 30 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOXAPAC, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 30 ml avec fermeture de sécurité enfant avec seringue(s) pour administration orale (polyéthylène, piston polystyrène)
- Marketing authorisation holder
- CNX THERAPEUTICS FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1980
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69700033CIP73233420CIP133400932334209Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LOXAPINEsolution | 2,50 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.